Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

All news Pharmasist News & insight

Quebec pharmacists contest $4-million delivery-payment allegations as hearing continues

Four pharmacists deny that specialty-drug delivery reimbursements were illegal benefits, arguing that actual delivery costs exceeded the payments. The OPQ hearing covers six alleged offences and continues November 27.

3 min read3 sources
Share LinkedIn X Facebook Email
Illustrative photo accompanying this news article
Montreal skyline, 2026; geographic file photo, not the pharmacies or hearing. Hayden Soloviev, CC BY 4.0; resized/WebP. Image source | Image source
In this article & details

Article details

Published
Nov 21, 2026
Reading time
3 min read
Categories
Pharmacy Business, Regulatory Update
Jurisdiction
Quebec
Sources cited
3
All news

Four Quebec pharmacists are contesting allegations that specialty-drug delivery reimbursements constituted illegal professional benefits, as disciplinary hearings examine payments reported to total more than $4 million over ten years. In November 21 reporting, Le Journal de Québec described defence testimony that the reimbursements covered only part of the pharmacies’ actual delivery expenses.

The Ordre des pharmaciens du Québec hearing record identifies Michael Assaraf, Daniel Vermette, Marc Chabot and Jérôme Bergeron as respondents in four files. It lists six alleged breaches of article 50 of the pharmacists’ code of ethics and hearings on November 18, 19, 20 and 27. These are contested disciplinary allegations, not findings that the payments were unlawful.

Regulator and pharmacists dispute the nature of the payments

In its November 20 account of the hearing, the newspaper reported that all four pharmacists pleaded not guilty. The dispute concerns reimbursements connected with delivering specialty medicines for people with rare diseases and cancers.

The report says the syndic treats the third-party payments as prohibited advantages related to professional practice. It describes the pharmacists’ opposing position: that reimbursement prevented losses on delivery and did not create a profit. The two sides presented forensic-accounting evidence concerning the pharmacies’ finances.

That distinction is central to the hearing. The regulator’s position, as reported, is that whether a pharmacy made a profit does not resolve whether the payment itself was an impermissible benefit. The pharmacists dispute both the characterization of the payments and the accounting behind the allegation.

Defence testimony puts remote delivery costs in focus

The November 21 follow-up describes payments for delivering compassionate-access doses: medicines supplied free to patients while public or private coverage is being arranged. Daniel Vermette testified that patient care was central to the pharmacies’ decisions, according to reporter Jean-Philippe Guilbault.

Albert Sayegh, vice-president of finance for Michael Assaraf’s pharmacies, testified that some deliveries to northern Quebec or the Îles-de-la-Madeleine could cost $300 to $500, while patient-support programs reimbursed an average of about $40. Those figures are defence evidence reported from the hearing, rather than amounts accepted in a published disciplinary finding.

Sayegh also said the pharmacies would continue delivering patients’ medicines regardless of the costs or reimbursements. Vermette described his cooperation with the investigation and argued that specialty practice differed from conventional community-pharmacy operations.

Six alleged offences remain before the council

The OPQ lists two counts in each of files 30-24-02220 and 30-24-02221, and one in each of files 30-24-02222 and 30-24-02223. All concern allegedly accepting illegal benefits related to professional practice. The record identifies Bernard Deshaies as syndic ad hoc and Georges Ledoux as the hearing’s presiding chair.

The official schedule provides for the November 27 sitting to take place by videoconference. Previous disciplinary proceedings involving these pharmacists are separate from the delivery-payment allegations now being heard. The current dispute remains before the disciplinary council.

References

  1. Hearing November 18, 19, 20 and 27, 2026 — files 30-24-02220 to 30-24-02223 — Ordre des pharmaciens du Québec
  2. Médicaments de spécialité : bras de fer entre l’Ordre des pharmaciens et quatre de ses membres — November 20, 2026 — Jean-Philippe Guilbault / Le Journal de Québec
  3. Les patients ont toujours été notre priorité — November 21, 2026 — Jean-Philippe Guilbault / Le Journal de Québec

Discussion

0 comments

Join the discussion. Anyone can read the comments. To comment, log in or create a free individual account.

No comments yet.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.